Wang, L., & Wang, W. (2021). Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer. Oncol Rep.
Chicago Style citaatWang, Li, en Wen Wang. "Safety and Efficacy of Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer." Oncol Rep 2021.
MLA citatieWang, Li, en Wen Wang. "Safety and Efficacy of Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer." Oncol Rep 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.